Platelets: still a therapeutical target for haemostatic disorders

Area of Science:

• Hematology
• Biotechnology
• Pharmacology

Background:

• Platelets are crucial blood components derived from megakaryocytes.
• Their involvement in hemostasis and pathological thrombosis is well-established.
• Understanding platelet mechanisms is key for therapeutic development.

Purpose of the Study:

• To review the fundamental mechanisms of platelet function.
• To examine the role of platelets in various syndromes and arterial thrombosis.
• To explore novel antithrombotic strategies targeting platelets and new biotechnological sources.

Main Methods:

• Literature review of platelet biology and thrombosis.
• Analysis of current and emerging antithrombotic agents.
• Exploration of biotechnological approaches for platelet generation.

Main Results:

• Detailed overview of platelet activation pathways and aggregation.
• Evidence linking platelet activity to arterial thrombosis and related syndromes.
• Identification of platelets as a promising target for antithrombotic drug design.
• Discussion of the feasibility of biotechnological platelet sources.

Conclusions:

• Platelets are central to thrombosis and represent a viable target for antithrombotic interventions.
• Further research into platelet mechanisms and biotechnological production holds significant therapeutic potential.